OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral
fluid diagnostics, today announced its support of numerous rapid
HIV testing initiatives in recognition of National HIV Testing Day,
held annually on June 27th. Now in its 17th year, National HIV
Testing Day is an annual event led by the National Association of
People with AIDS (NAPWA) to encourage the millions of Americans who
are at-risk for HIV to receive voluntary HIV counseling and
testing.
OraSure's support of these initiatives includes collaborations
with NAPWA, Greater Than AIDS and Walgreens to promote rapid HIV
testing in cities across the U.S. Additionally, OraSure will host
the NASDAQ Stock Market Open Ceremony and a special HIV testing
industry panel discussion both taking place today.
"We are very proud to once again work with NAPWA and hundreds of
city officials, public health departments, community-based
organizations and hospitals nationwide in support of National HIV
Testing Day," said Douglas A. Michels, President and CEO of OraSure
Technologies. "Of the 1.1 million Americans estimated to be
infected with HIV, more than 200,000 are unaware of their
infection. HIV testing is the first step to learning one's HIV
status. We are proud that our technology is a driving force
in getting more people tested and enabling HIV-positive individuals
to learn their status earlier so they can access care sooner."
"It's more important this year than ever for all Americans to
get tested regularly," said Frank J. Oldham Jr., NAPWA's President
and Chief Executive Officer. "Not only do people with HIV do better
medically when they start treatment, but we now have proof that
people in treatment for HIV are less likely to infect others.
Routine testing is the first step towards having more people with
HIV in treatment."
Key highlights include:
Mayor's Campaign Against HIV
OraSure has collaborated with NAPWA to launch the seventh annual
Mayor's Campaign Against HIV™, a national campaign to encourage
testing for HIV and promote the benefits of knowing one's HIV
status. The Campaign is part of the annual observance of National
HIV Testing Day.
NAPWA and OraSure have worked with city public health
departments and community-based organizations across the country to
elicit mayoral support to urge HIV testing and prevention among
their constituencies. More than 100 Mayors in cities nationwide
have committed their participation and support, including Atlanta,
Baltimore, Chicago, Cleveland, Houston, Kansas City, Philadelphia,
and Washington, D.C. Several Mayors have also committed to
getting tested today while others are issuing proclamations or
holding press conferences to encourage individuals to get tested
for HIV.
NASDAQ MarketSite and HIV Testing Panel
OraSure will open the NASDAQ MarketSite today. Guests for the
market open will include Frank Oldham, President and CEO of NAPWA,
Johnny Ford, founder of the World Conference of Mayors and former
mayor of Tuskegee, AL, Robert L. Bowser, Mayor of East Orange, NJ
and President of the National Black Conference of Mayors and Ronald
K. Davis, Mayor of Prichard, AL and President of the World
Conference of Mayors. A live webcast of the NASDAQ Opening Bell
will be available at:
http://www.nasdaq.com/reference/marketsite_about.stm
Immediately following the opening, OraSure will also host at the
NASDAQ MarketSite a panel discussion by experts who have
successfully integrated routine rapid HIV testing in a variety of
clinical and non-clinical settings. The panel members will share
their best practices for implementing HIV testing.
HIV Testing in Times Square, NYC
In conjunction with the NASDAQ open and panel discussion,
Community Healthcare Network will offer free rapid HIV testing
today in Times Square using the OraQuick ADVANCE® test at its
mobile HIV testing van.
Walgreens / Greater Than AIDS HIV Testing
OraSure is also collaborating with Greater Than AIDS, the
Centers for Disease Control and Prevention, local departments of
health and community-based organizations across the U.S. to provide
free screenings for HIV at select Walgreens retail pharmacies in
major cities including Atlanta, Chicago, Dallas, Houston, Miami,
New Orleans, Oakland and San Francisco. This is part of an
ongoing national campaign by Walgreens and Greater Than AIDS to
respond to HIV/AIDS in the U.S. OraQuick tests were offered by
the local agencies at select Walgreens locations from June 22 -
24.
OraQuick ADVANCE® is the first and only FDA-approved and
CLIA-waived rapid point-of-care test that can detect antibodies to
both HIV-1 and HIV-2 in 20 minutes, using oral fluid, finger-stick
or venipuncture whole blood or plasma specimens. As the market
leader in rapid HIV testing, OraQuick ADVANCE® is used extensively
throughout the country in public health settings, hospitals,
community-based organizations, and physician offices where HIV
testing is conducted.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral
fluid specimen collection devices using proprietary oral fluid
technologies, diagnostic products including immunoassays and other
in vitro diagnostic tests, and other medical devices. These
products are sold in the United States as well as internationally
to various clinical laboratories, hospitals, clinics,
community-based organizations and other public health
organizations, distributors, government agencies, physicians'
offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid
testing solutions for drugs of abuse and for the detection of
antibodies to HIV.
For more information on the Company, please go to
www.orasure.com.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: Media Contact:
Jennifer Moritz
Zer0 to 5ive for OraSure Technologies
917-748-4006
jmoritz@0to5.com
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024